因美纳致力于以技术助力科研人员,深化对人类疾病的理解。随着癌症研究日益依赖基因组与表观基因组的整合视角,本次资助项目旨在支持运用这些洞察推动科学发现、改善人类健康的研究创新。
借助因美纳“癌症研究5 Base解决方案资助项目”,更深入地了解基因组与表观基因组
因美纳致力于以技术助力科研人员,深化对人类疾病的理解。随着癌症研究日益依赖基因组与表观基因组的整合视角,本次资助项目旨在支持运用这些洞察推动科学发现、改善人类健康的研究创新。
因美纳“癌症研究5‑Base解决方案资助项目”旨在通过为科研人员提供创新的因美纳5‑Base解决方案,加速癌症表观遗传学领域的突破性发现。本项目支持通过整合分析遗传与表观遗传变异来深化对癌症机制的研究理解。
项目核心目标包括:
因美纳5-Base解决方案可同步检测遗传与表观遗传变异,为解析癌症机制提供一体化研究路径。本项目邀请符合条件的研究人员提交基于Illumina 5-Base DNA Prep或Illumina 5-Base DNA Prep with Enrichment试剂盒开展、具有重要影响力的癌症主题研究方案。
了解更多关于因美纳Illumina 5-base解决方案的信息
符合条件的申请者可提交400字的项目摘要,阐述使用因美纳5-Base解决方案开展的全新研究。本资助项目将提供足以支持多达1000个样本的试剂盒与核心耗材。申请截止日期为太平洋时间2026年6月26日晚上11:59。
专家组将从所有合格的申请中评选出一名获奖者,申请的入选标准如下:
优胜者将获得Illumina 5-Base DNA Prep或Illumina 5-Base DNA Prep with Enrichment试剂盒及足以支持多达1000个样本分析的核心耗材(奖品)。
获奖名单将于2026年7月29日公布。
申请开始:2026年4月15日
提交截止:2026年6月26日
获奖公布:2026年7月29日
本次资助项目面向学术界、非营利机构及营利机构的基因组学基础科研人员开放
申请者应在项目总结中包含以下内容:
由因美纳科学家和高管组成的评审小组将根据科学价值、创新性及与因美纳价值观的契合度对申请方案进行评审。
All grant submissions are confidential to the individual submitter and will not be published or distributed, provided, however, Illumina may share them with their own staff and distributors, who will not disclose them to third parties. Illumina may support the grant advertising efforts.
The winner will be selected by a panel of judges selected by Illumina. The panel may include representatives from Illumina. Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by Illumina and the winner: webinar, press release, case study, blog post, poster presentation, and/or conference presentation. The winner agrees that Illumina shall have the right to publicly announce the winner’s name and research title and use anonymized data from the winner's projects in application notes including in marketing materials and seminars—no public display of data will happen without prior consent from the winner.
Applicants must be 18 years of age or older and actively enrolled or employed at a research institution in a capacity in which they perform life science research and can process samples within six (6) months of award notification.
By submitting a grant application, each applicant agrees that Illumina may use his or her name, abstract title, for marketing purposes.
Illumina or its affiliates may disclose the grant, including its terms, the identity of the winner, the nature of the relationship, the Prize (including it's monetary value), and any other transfers of value, in order to comply with applicable transparency laws and standards (e.g., Physician Payments Sunshine Act, Loi Bertrand, MedTech Europe, etc.).
All grant applicants agree that Illumina may process the personal data he or she provides as part of application, including sharing such data with Illumina’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with Illumina’s privacy policies.
Applicants agree that Illumina may use applicant’s names, email addresses and affiliated institution to contact applicants for purposes of marketing of its products and services in accordance with the Illumina privacy policy here.
The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by Illumina. No substitution or transfer of the awarded prize is allowed except as permitted by Illumina. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of Illumina, then Illumina reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. These terms and conditions and any action related to this grant program will be governed by the laws of the State of California without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in San Diego County, California, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.
参加因美纳5‑Base解决方案研究资助项目,将为致力于推动癌症研究的科研人员带来重要助益。除了可能获得奖项外,申请者还将获得提升专业知名度、拓展合作网络的机遇,并为未来争取其他资助奠定基础。
优胜项目将通过因美纳官网及社交媒体渠道进行重点宣传。此次曝光将提升研究人员的学术形象,扩展其工作的影响力,并有助于提高业界对创新癌症研究方法的关注。通过这些渠道的展示,项目有望开启新的合作机会,吸引更广泛的科学界兴趣,从而巩固研究人员的专业地位。
优胜者会受邀在因美纳主办的网络研讨会、专题研讨会、采访和/或其他活动上展示研究成果。此平台让研究人员能够直接与基因组学领域的同行、技术专家和领导者展开交流互动。在此类场合展示研究成果,能够激发有价值的联系,支持知识交流,并有助于建立推动未来科学进展的新合作伙伴关系。
撰写一份出色的申请材料有助于获得机构支持,并让您的研究项目在争取其他外部资助时占据有利位置。这个过程可能会帮助您发现新的合作者、完善研究假设,或揭示拓展研究范围的新机遇。
准备好提交您的研究方案了吗?请通过申请链接提交400字的项目摘要、辅助材料及所需信息。所有申请材料必须完整、原创,并在太平洋时间2026年6月26日晚上11:59之前成功提交。